These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30766775)

  • 21. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations.
    Kissi EO; Kasten G; Löbmann K; Rades T; Grohganz H
    Mol Pharm; 2018 Sep; 15(9):4247-4256. PubMed ID: 30020794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
    Newman A; Zografi G
    Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.
    Wang S; Heng W; Wang X; He X; Zhang Z; Wei Y; Zhang J; Gao Y; Qian S
    Int J Pharm; 2020 Oct; 588():119793. PubMed ID: 32827676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
    Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
    J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
    Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
    J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc.
    Zhu H; Padden BE; Munson EJ; Grant DJ
    J Pharm Sci; 1997 Apr; 86(4):418-29. PubMed ID: 9109042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition Temperature.
    Ueda H; Hirakawa Y; Miyano T; Imono M; Tse JY; Uchiyama H; Tozuka Y; Kadota K
    Mol Pharm; 2022 Apr; 19(4):1209-1218. PubMed ID: 35316068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy.
    Fang X; Hu Y; Huang Z; Han L; Li B; Lu S; Cao Y
    J Pharm Sci; 2022 Jul; 111(7):2056-2071. PubMed ID: 35167885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
    Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
    Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems.
    Albarahmieh E; Qi S; Craig DQM
    Int J Pharm; 2016 Nov; 514(1):270-281. PubMed ID: 27863672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous Form and Solubility Enhancement in Solution.
    Lalge R; Kaur N; Duggirala NK; Suryanarayanan R
    Mol Pharm; 2022 Jul; 19(7):2595-2606. PubMed ID: 35687125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
    Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
    Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies.
    McFall H; Sarabu S; Shankar V; Bandari S; Murthy SN; Kolter K; Langley N; Kim DW; Repka MA
    Int J Pharm; 2019 Jan; 554():302-311. PubMed ID: 30395959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Dynamics and Physical Stability of Coamorphous Ezetimib and Indapamide Mixtures.
    Knapik J; Wojnarowska Z; Grzybowska K; Jurkiewicz K; Tajber L; Paluch M
    Mol Pharm; 2015 Oct; 12(10):3610-9. PubMed ID: 26301858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injection-Molded Coamorphous Tablets: Analysis of Intermolecular Interaction and Crystallization Propensity.
    Tanaka R; Ishihara S; Sasaki T; Hattori Y; Otsuka M
    J Pharm Sci; 2021 Sep; 110(9):3289-3297. PubMed ID: 34147517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
    Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
    Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.